Learn / Clinical Research Management / Monitoring, quality and inspection
Monitoring: visits, remote checks and risk-based approaches
13 minute read · 6-question quiz
What you will learn
Describe the types of monitoring visit and what happens at each
Explain risk-based and central monitoring
Write a clear monitoring visit report and follow-up letter
Monitoring is the act of overseeing the progress of a trial and ensuring that it is conducted, recorded and reported in accordance with the protocol, SOPs, GCP and regulations. The person who does this for the sponsor or CRO is the monitor or clinical research associate (CRA).
Types of monitoring visit
- Pre-study (site qualification) visit: assesses whether a site is suitable.
- Site initiation visit: trains and prepares the site.
- Interim monitoring visits (IMVs): repeated visits during the trial to check compliance and data.
- Close-out visit: closes the site at the end of the trial.
What happens at an interim visit
- Preparation: review previous reports, outstanding issues, new data, and plan the agenda.
- Opening meeting with the PI and team.
- Review of consent forms: every participant has a properly signed, dated form before study procedures, and the correct version.
- Source data verification: compare CRFs with source documents, using the plan to select what to check.
- Safety review: SAE reporting and follow-up.
- IP accountability and storage checks.
- Investigator Site File review: current approvals, logs, certificates.
- Facility and staff checks.
- Closing meeting to discuss findings and actions.
- Report and follow-up letter to the site and sponsor, with actions and deadlines.
Risk-based and remote monitoring
Checking everything on every page at every visit is costly and not always the best use of effort. Risk-based monitoring (RBM) focuses effort on the data and processes most important to participant safety and to the reliability of the results.
- A risk assessment identifies critical data (such as primary endpoint and safety data) and processes (consent, randomisation, IP handling).
- Key risk indicators (KRIs) such as late data entry, high AE under-reporting signals, protocol deviations, or missed visits flag sites needing attention.
- Centralised (remote) monitoring uses data trends, statistical checks and remote review of documents to find problems, guiding where and when to visit.
- Targeted SDV replaces 100% SDV with checks on critical data and a sample of other data.
Regulators encourage these approaches, which became common during COVID-19.
Summary
Monitoring checks conduct, data and safety through pre-study, initiation, interim and close-out visits.
Interim visits review consent, SDV, safety, IP and the site file.
Risk-based and central monitoring target oversight to critical data and high-risk sites.
Reports must classify findings and drive timely follow-up.
Check your understanding
Draft study guide. Spotted an error or something unclear? Tell us at hello@scintria.com. This is educational material, not clinical or regulatory advice.